The efficacy of benzimidazole drugs against Plasmodium falciparum in vitro

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 91, Issue 5, 1997, Pages 580-584

  Skinner Adams, Tina S ^a   Davis, Timothy M E ^a   Manning, Linda S ^b   Johnston, Wayne A ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b FREMANTLE HOSPITAL   (Australia)

Author keywords

Benzimidazoles; Chemotherapy; Chloroquine; Drug sensitivity; Malaria; Plasmodium falciparum; Quinine

Indexed keywords

ALBENDAZOLE; ALBENDAZOLE SULFONE; ALBENDAZOLE SULFOXIDE; ANTIMALARIAL AGENT; BENZIMIDAZOLE; BENZIMIDAZOLE DERIVATIVE; CHLOROQUINE; MEBENDAZOLE; OMEPRAZOLE; QUININE; TIABENDAZOLE; TUBULIN;

ANTIMALARIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG METABOLISM; DRUG POTENCY; GROWTH INHIBITION; MICROTUBULE ASSEMBLY; NONHUMAN; PH; PLASMODIUM FALCIPARUM; SCHIZONT; TROPHOZOITE;

CINCHONA PUBESCENS; PLASMODIUM FALCIPARUM;

EID: 0030662679     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(97)90035-3     Document Type: Article

References (29)

1. Andersson, T. (1996). Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Clinical Pharmacokinetics, 31, 9-28.
2. Bell, A.,Wernli, B. & Franklin, R. M. (1993). Effects of microtubule inhibitors on protein synthesis in Plasmodium falciparum. Parasitology Research, 79, 146-152.
3. Chang, M., Dahl, M., Tybring, G., Gotharson, E. & Bertilsson, L. (1995). Use of omeprazole as a probe in Swedish Caucasians: comparison with S-mephenytoin hydroxylation phenotype and CYP2C19 genotype. Pharmacogenetics, 5, 358-368.
4. Cowman, A. F. & Foote, S. J. (1990). Chemotherapy and drug resistance in malaria. International Journal for Parasitology, 20, 503-513.
5. Desjardins, R. E., Canfield, C. J., Haynes, J. D. & Chulay, J. D. (1979). Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrobial Agents and Chemotherapy, 16, 710-718.
6. Dharnidharka, V. R., Agrawal, M. & Dandge, V. P. (1993). Albendazole. Indian Pediatrics, 30, 1115-1118.
7. Dieckman-Schuppert, A. & Franklin, R. M. (1989). Compounds binding to cytoskeletal proteins are active against Plasmodium falciparum in vitro. Cell Biology International Reports, 13, 207-214.
8. Dieckman-Schuppert, A. & Franklin, R. M. (1990). Mode of action of tubulozoles against Plasmodium falciparum in vitro. Antimicrobial Agents and Chemotherapy, 34, 1529-1533.
9. Geary, T. G., Divo, A. A. & Jensen, J. B. (1989). Stage specific actions of antimalarial drugs on Plasmodium falciparum in culture. American Journal of Tropical Medicine and Hygiene, 40, 240-244.
10. Horton, R. J. (1990). Benzimidazoles in a wormy world. Parasitology Today, 6, 106.
11. 50 in studies of drug resistance of malaria parasites. Acta Tropica, 55, 257-261.
12. Karcz, S. R., Herrmann, V. R. & Cowman, A. F. (1993). Cloning and characterization of a vacuolar ATPase A subunit homologue from Plasmodium falciparum. Molecular and Biochemical Parasitology, 58, 333-344.
13. Karcz, S. R., Herrmann, V. R. & Cowman, A. F. (1994). Cloning and characterization of the vacuolar ATPase B subunit from Plasmodium falciparum. Molecular and Biochemical Parasitology, 68, 123-133.
14. Lambros, C. & Vanderberg, J. P. (1979). Synchronization of Plasmodium falciparum erythrocytic stages in culture. Journal of Parasitology, 65, 418-420.
15. Lanusse, C. E. & Prichard, R. K. (1993). Clinical pharmacokinetics and metabolism of benzimidazole anthelmintics in ruminants. Drug Metabolism Reviews, 25, 235-279.
16. Marriner, S. D., Morris, D. L., Dickson, B. & Bogan, J. A. (1986). Pharmacokinetics of albendazole in man. European Journal of Clinical Pharmacology, 30, 705-708.
17. Maton, P. N. (1991). Omeprazole. New England Journal of Medicine, 324, 965-975.
18. McQuaid, K. R. & Knauer, C. M. (1994). Alimentary tract. In: Current Medical Diagnosis and Treatment, Tierney, L. M., McPhee, S. J. & Papadakis, M. A. (editors). California: Lange Medical, pp. 467-527.
19. Meloni, B. P., Thompson, R. C. A., Reynoldson, J. A. & Seville, P. (1990). Albendazole: a more effective antigiardial agent in vitro than metronidazole or tinidazole. Transactions of the Royal Society of Tropical Medicine and Hygiene, 84, 375-379.
20. Peters, W. (1990). Plasmodium: resistance to antimalarial drugs. Annales de Parasitologie Humaine et Comparée, 65, 103-106.
21. Reynoldson, J. A.,Thompson, R. C. A. & Meloni, B. P. (1992). The potential and possible mode of action of the benzimidazoles against Giardia and other protozoa. Journal of Pharmaceutical Medicine, 2, 35-50.
22. Tanabe, K. (1990). Iron metabolism in malaria-infected erythrocytes. Blood Cells, 16, 437-449.
23. Ter Kuile, F., White, N. J., Holloway, P., Pasvol, G. & Krishna, S. (1993). Plasmodium falciparum: in vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria. Experimental Parasitology, 76, 85-95.
24. Trager, W. & Jensen, J. B. (1976). Human malaria parasites in continuous culture. Science, 89, 673-675.
25. Vinayek, R., Amantea, M. A., Maton, P. N., Frucht, H., Gardner, J. D. & Jensen, R. T. (1991). Pharmacokinetics of oral and intravenous omeprazole in patients with the Zollinger-Ellison syndrome. Gastroenterology, 101, 138-147.
26. Warhurst, D. C. (1986). Antimalarial drugs: mode of action and resistance. Journal of Antimicrobial Chemotherapy, 8, 51-59.
27. White, N. J. (1992). Antimalarial drug resistance; the pace quickens. Journal of Antimicrobial Chemotherapy, 30, 571-585.
28. Wilde, M. I. & McTavish, D. (1994). Omeprazole. An update of its pharmacology and therapeutic use in acid-related disorders. Drugs, 48, 91-132.
29. Yayon, A., Cabantchil, Z. I. & Ginsburg, H. (1985). Susceptibility of human malaria parasites to chloroquine is pH dependent. Proceedings of the National Academy of Sciences of the USA, 82, 2784-2788.